Form D Explorer
Duo Oncology Inc. · CIK 1843372

Report a data issueCitable research briefCompare issuerPrivate research collection

Duo Oncology Inc.

CIK 1843372 · Corporation · Inc. DELAWARE · PITTSBURGH, Pennsylvania · Pharmaceuticals

Filing history at a glance

The reported offering amount was $3,000,000 in the Jun 9, 2026 filing and $3,500,000 in the Aug 7, 2026 filing. The two records may concern different offerings. Amendments account for 2 of the 3 filings stored from Jun 10, 2025 to Aug 7, 2026.

Filings
3
Original notices
1
Amendments
2
Activity
Jun 10, 2025
through Aug 7, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldJun 9, 2026 · D/AAug 7, 2026 · D/ALater minus earlier
Reported offering amount$3,000,000$3,500,000$500,000
Reported amount sold$1,425,000$1,625,000$200,000
Reported investor count13130
Reported minimum investment$25,000$25,000$0

Earlier SEC source: 0001843372-26-000004 · Later SEC source: 0001843372-26-000005

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot

Form D/A · Aug 7, 2026

Reported offering amount
$3,500,000
Reported exemptions
Rule 506(b)
Reported amount sold
$1,625,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (3)